Agios Pharmaceuticals Inc. (AGIO) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Agios Pharmaceuticals Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$38.12
+0.24% today
Market cap
$2.3B
Overall quality
47/100
Kronos AI 30-day
−11.8%
0 of 8 simulated paths end higher
Agios Pharmaceuticals Inc. (AGIO) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $2.3B. It trades at $38.12, up 0.24% today. Its overall quality score is 47 out of 100, ranked against the whole US market. 6 analysts' average target of $45.20 implies +18.6% from today's price. Kronos AI's 30-day forecast is −11.8% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $45.20 |
| Low – high | $32.00 – $55.00 |
| Analysts | 6 |
| Upside to average | +18.6% |
Kronos AI 30-day forecast
| Expected close | $33.52 (−11.8%) |
| Likely range | −18.1% … −4.6% |
| As of | 2026-10-27 |
0 of 8 simulated paths end higher.
Quality scores
| Profitability | 12 |
| Solvency | 56 |
| Growth | 72 |
| Overall | 47 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.